These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

99 related items for PubMed ID: 7303809

  • 1. [Double blind study on the hemodynamic effects of amezinium methlsulfate in patients with orthostatic circulatory disorders (author's transl)].
    Belz GG, Aust PE, Belz G.
    Z Kardiol; 1981 Sep; 70(9):706-12. PubMed ID: 7303809
    [No Abstract] [Full Text] [Related]

  • 2. [Orthostatic regulation and its modification by amezinium].
    Rieckert H.
    Med Welt; 1983 Jan 14; 34(2):60-2. PubMed ID: 6827961
    [No Abstract] [Full Text] [Related]

  • 3. [Therapy of hypotonic cardiovascular regulation disorders with amezinium (Regulton) and dihydroergotamine].
    Bückert C.
    Fortschr Med; 1981 Aug 13; 99(30):1202-6. PubMed ID: 7024066
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. [Comparative studies of the efficacy of amezinium and etilefrin in aged patients with hypotonic blood circulation regulatory disorders].
    Jansen W.
    Med Welt; 1982 Oct 02; 32(40):1491-6. PubMed ID: 6125868
    [No Abstract] [Full Text] [Related]

  • 6. [Evaluation of the effectiveness of Thomasin (etilefrin) in hypotensive and/or orthostatic circulatory disorders in comparison with pholedrine and placebo (double-blind study)].
    Gruber G.
    Z Arztl Fortbild (Jena); 1982 Feb 15; 76(4):149-53. PubMed ID: 6125062
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. [Therapy of age-induced hypotension and hypotensive orthostatic regulation disorders using Regulton].
    Harwart D.
    Fortschr Med; 1983 Jan 20; 101(3):94-8. PubMed ID: 6826139
    [No Abstract] [Full Text] [Related]

  • 9. [Studies on the effect of the alpha-receptor stimulant, gutron, in the orthostatic syndrome (author's transl)].
    Scholing WE.
    Wien Klin Wochenschr; 1981 Jun 26; 93(13):429-34. PubMed ID: 6168121
    [Abstract] [Full Text] [Related]

  • 10. Norepinephrine precursor therapy in neurogenic orthostatic hypotension.
    Kaufmann H, Saadia D, Voustianiouk A, Goldstein DS, Holmes C, Yahr MD, Nardin R, Freeman R.
    Circulation; 2003 Aug 12; 108(6):724-8. PubMed ID: 12885750
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Gutron treatment of patients suffering from essential orthostatic hypotony. Part One--Hemodynamic non-invasive investigation.
    Axenti I, Petelenz T, Sosnoski M, Slomińska-Petelenz T.
    Int Angiol; 1993 Jun 12; 12(2):132-7. PubMed ID: 7690384
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. [Dihydergot plus - 12-hour action in orthostatic disturbance and hypotension].
    Schardt F, Mishra BR.
    Ther Ggw; 1982 Jan 12; 121(1):26-36. PubMed ID: 6121387
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. [Treatment of hypotensive circulatory dysregulation with a combination of dihydroergotamine and etilefrine (author's transl)].
    Bracharz H, Polzien P.
    MMW Munch Med Wochenschr; 1981 Jan 30; 123(5):177-80. PubMed ID: 6110188
    [Abstract] [Full Text] [Related]

  • 18. [Therapy of orthostatic dysregulation: dihydroergotamine and etilefrin as a combination compared to the monosubtances].
    Polzien P, Bracharz H.
    Med Klin; 1980 Dec 05; 75(25):878-82. PubMed ID: 6110162
    [No Abstract] [Full Text] [Related]

  • 19. [Experiences with the new antihypotensive agent Regulton in general practice].
    Stoidner B.
    ZFA (Stuttgart); 1983 May 31; 59(15):895-901. PubMed ID: 6880365
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 5.